![Stephen Squinto](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stephen Squinto
Chairman at
Chemomab Ltd.
Profile
Dr. Stephen P.
Squinto is a Chief Investment Officer at JP Morgan Life Sciences Private Capital and a Chairman at Chemomab Ltd. He is on the Board of Directors at SpringWorks Therapeutics LLC, SmartZyme Biopharma, Inc., Nutrinia Ltd., Chamishi Therapeutics, Inc., Emendo Biotherapeutics, Inc., Q32 Bio Operations, Inc., The UCAN Co. and VectivBio AG.
Dr. Squinto was previously employed as a Chairman by Genenta Science SpA, a Chairman by Chemomab Therapeutics Ltd., a Chairman, President, CEO, Secretary & Treasurer by Gennao Bio, Inc., an Independent Director by VectivBio Holding AG, a Vice Chairman by bioAffinity Technologies, Inc., a Director, Head-Research & Development by Passage Bio, Inc., an Independent Director by Arvinas Holding Co. LLC, an Independent Director by Audentes Therapeutics, Inc., an Independent Director by Compass Therapeutics, Inc., an Executive Partner by OrbiMed Advisors Private Equity, a Chief Global Operations Officer & Executive VP by Alexion Pharmaceuticals, Inc., a Senior Scientist & Assistant Head-Discovery Group by Regeneron Pharmaceuticals, Inc., an Assistant Professor by Louisiana State University, a Chairman by Gemini Therapeutics Sub, Inc., a President-Greater New Haven Chapter by Juvenile Diabetes Research Foundation Ltd., a Chairman by Lyfebulb LLC, and a Member-Supervisory Board by Therachon Holding GmbH.
He also served on the board at Olivia Ventures, Inc., Aspen Neuroscience, Inc., Springworks Therapeutics, Inc., Compass Therapeutics LLC, Biotechnology Research & Development Corp., 89bio, Inc., Arradial, Inc., Arvinas Operations, Inc., GlyGenix Therapeutics, Inc., iECURE, Inc. and Promentis Pharmaceuticals, Inc. He received his undergraduate degree from Loyola University of Chicago and a doctorate degree from Loyola University of Chicago.
Stephen Squinto active positions
| Companies | Position | Start |
|---|---|---|
Chemomab Ltd.
 Chemomab Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biotechnology company that develops therapeutics for fibro-inflammatory diseases | Chairman | 04/12/2018 |
SmartZyme Biopharma, Inc.
 SmartZyme Biopharma, Inc. Miscellaneous Commercial ServicesCommercial Services Provides platform for protein design and engineering of both new and better therapeutics | Director/Board Member | 27/10/2015 |
Nutrinia Ltd.
 Nutrinia Ltd. Pharmaceuticals: MajorHealth Technology Develops bioactive feed supplements for infant formulas and animal feed | Director/Board Member | 30/06/2015 |
SpringWorks Therapeutics LLC
 SpringWorks Therapeutics LLC BiotechnologyHealth Technology Operates as a commercial-stage biopharmaceutical company that develops oncology medicines | Director/Board Member | 01/01/2017 |
The UCAN Co.
 The UCAN Co. Pharmaceuticals: OtherHealth Technology Manufactures and retails energy gels, hydration products, protein powders & energy bars through online | Director/Board Member | - |
Q32 Bio, Inc.
 Q32 Bio, Inc. BiotechnologyHealth Technology Develops immunomodulatory therapies with protein based molecules using a platform | Director/Board Member | - |
Emendo Biotherapeutics, Inc.
 Emendo Biotherapeutics, Inc. BiotechnologyHealth Technology Operates genome editing company that develops genetic medicines and cell therapies for severe diseases | Director/Board Member | - |
Chamishi Therapeutics, Inc.
 Chamishi Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a drug development company | Director/Board Member | - |
VectivBio AG
 VectivBio AG BiotechnologyHealth Technology Operates as biotechnology company | Director/Board Member | - |
Former positions of Stephen Squinto
| Companies | Position | End |
|---|---|---|
| ░░░░░░ ░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░ ░░░░░░░ ░░░░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Education of Stephen Squinto
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
74
1st degree connections
38
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 38 |
|---|---|
Regeneron Pharmaceuticals, Inc.
 Regeneron Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops, manufactures and commercializes medicines for diseases | Health Technology |
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops life-changing therapies for people living with rare disorders | Health Technology |
The UCAN Co.
The UCAN Co. Pharmaceuticals: OtherHealth Technology Manufactures and retails energy gels, hydration products, protein powders & energy bars through online | Health Technology |
Promentis Pharmaceuticals, Inc.
 Promentis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for neuropsychiatric disorders | Health Technology |
Arvinas Operations, Inc.
 Arvinas Operations, Inc. BiotechnologyHealth Technology Develops protein degradation therapeutics for cancer and other diseases | Health Technology |
Compass Therapeutics LLC
 Compass Therapeutics LLC BiotechnologyHealth Technology Operates in the healthcare industry focusing on biotechnology business | Health Technology |
Louisiana State University
 Louisiana State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Loyola University of Chicago
 Loyola University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OrbiMed Advisors Private Equity
 OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity invests in companies located across the globe primarily in North America, Asia, Europe and Israel. The firm focuses on biopharmaceuticals, medical technology and healthcare services. It participates in seed-stage, early stage, growth transactions. It also provides debt capital and monetize royalty streams and invests in publicly-traded companies. | Finance |
Biotechnology Research & Development Corp.
 Biotechnology Research & Development Corp. Miscellaneous Commercial ServicesCommercial Services Provides research on animal and plant healthcare, material sciences and biotechnology | Commercial Services |
Nutrinia Ltd.
Nutrinia Ltd. Pharmaceuticals: MajorHealth Technology Develops bioactive feed supplements for infant formulas and animal feed | Health Technology |
Arradial, Inc. | |
Juvenile Diabetes Research Foundation Ltd.
 Juvenile Diabetes Research Foundation Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in prevention, treatment, causes and cure for diabetes | Commercial Services |
Astellas Gene Therapies, Inc.
 Astellas Gene Therapies, Inc. BiotechnologyHealth Technology Develops and commercializes gene therapy products for patients with serious rare diseases | Health Technology |
GlyGenix Therapeutics, Inc.
 GlyGenix Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutic products for the treatment of cure metabolic disorders | Health Technology |
bioAffinity Technologies, Inc.
 bioAffinity Technologies, Inc. Medical SpecialtiesHealth Technology Develops vitro diagnostic tests and targeted cancer therapeutics for early-stage cancer diagnostics | Health Technology |
Arvinas, Inc.
 Arvinas, Inc. BiotechnologyHealth Technology Engages in discovery, development and commercialization of therapies to degrade disease-causing proteins | Health Technology |
SmartZyme Biopharma, Inc.
SmartZyme Biopharma, Inc. Miscellaneous Commercial ServicesCommercial Services Provides platform for protein design and engineering of both new and better therapeutics | Commercial Services |
Chemomab Ltd.
Chemomab Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biotechnology company that develops therapeutics for fibro-inflammatory diseases | Commercial Services |
Gemini Therapeutics Sub, Inc.
 Gemini Therapeutics Sub, Inc. BiotechnologyHealth Technology Develops drugs for dry age-related macular degeneration and associated rare genetic diseases | Health Technology |
Genenta Science SpA
 Genenta Science SpA Aerospace & DefenseElectronic Technology Develops and manufactures aerospace & defense products, cybersecurity, AI-driven intelligence and quantum technologies | Electronic Technology |
SpringWorks Therapeutics LLC
SpringWorks Therapeutics LLC BiotechnologyHealth Technology Operates as a commercial-stage biopharmaceutical company that develops oncology medicines | Health Technology |
Olivia Ventures, Inc.
 Olivia Ventures, Inc. Financial ConglomeratesFinance Operates as blank check company | Finance |
Therachon Holding GmbH
 Therachon Holding GmbH BiotechnologyHealth Technology Develops medical treatments for rare conditions | Health Technology |
89bio, Inc.
 89bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Passage Bio, Inc.
 Passage Bio, Inc. BiotechnologyHealth Technology Develops therapies for the treatment of monogenic central nervous system disorders | Health Technology |
Springworks Therapeutics, Inc.
 Springworks Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for treating cancer | Health Technology |
Emendo Biotherapeutics, Inc.
Emendo Biotherapeutics, Inc. BiotechnologyHealth Technology Operates genome editing company that develops genetic medicines and cell therapies for severe diseases | Health Technology |
Aspen Neuroscience, Inc.
 Aspen Neuroscience, Inc. BiotechnologyHealth Technology Operates as a clinical-stage regenerative medicine biotechnology company and develops autologous induced-pluripotent stem cell | Health Technology |
Q32 Bio, Inc.
Q32 Bio, Inc. BiotechnologyHealth Technology Develops immunomodulatory therapies with protein based molecules using a platform | Health Technology |
Chamishi Therapeutics, Inc.
Chamishi Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a drug development company | Health Technology |
VectivBio Holding AG
 VectivBio Holding AG Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics for rare diseases | Health Technology |
Compass Therapeutics, Inc.
 Compass Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage oncology biopharmaceutical company that develops antibody based therapeutics to treat multiple human diseases | Health Technology |
Lyfebulb LLC
 Lyfebulb LLC Internet Software/ServicesTechnology Services Operates as an online digital platform for people living with chronic illnesses | Technology Services |
VectivBio AG
VectivBio AG BiotechnologyHealth Technology Operates as biotechnology company | Health Technology |
Chemomab Therapeutics Ltd.
 Chemomab Therapeutics Ltd. BiotechnologyHealth Technology Operates as a clinical-stage biotech company | Health Technology |
IEcure, Inc.
 IEcure, Inc. BiotechnologyHealth Technology Operates as a a clinical-stage biotechnology company that develops in-vivo gene insertion/editing therapies to treat rare liver disorders | Health Technology |
Gennao Bio, Inc.
 Gennao Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops targeted nucleic acid therapeutics to cure muscle diseases | Health Technology |
- Stock Market
- Insiders
- Stephen Squinto
